{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:59:03Z","timestamp":1790398743062,"version":"4.1.0"},"reference-count":7,"publisher":"Keio Journal of Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Keio J. Med.","Keio j. med"],"published-print":{"date-parts":[[2026]]},"DOI":"10.2302\/kjm.2025-0020-le","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:08:56Z","timestamp":1769119736000},"page":"51-54","source":"Crossref","is-referenced-by-count":0,"title":["Identifying High-Cost RSV Hospitalizations at a Secondary Hospital in          Japan"],"prefix":"10.2302","volume":"75","author":[{"given":"Tomomi","family":"Matsuda","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Keio University School of Medicine, Tokyo,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Seki","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, Saitama City Hospital,              Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Akashi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saitama City Hospital, Saitama,              Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushige","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, Saitama City Hospital,              Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1082","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Hall CB, Weinberg GA, Blumkin AK, Edwards KM,          Staat MA, Schultz AF, Poehling KA, Szilagyi PG, Griffin MR, Williams JV, Zhu Y, Grijalva          CG, Prill MM, Iwane MK: Respiratory syncytial virus-associated hospitalizations among          children less than 24 months of age. Pediatrics 2013; 132: e341\u2013e348. PMID:23878043          https:\/\/doi.org\/10.1542\/peds.2013-0303","DOI":"10.1542\/peds.2013-0303"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Sruamsiri R, Kubo H, Mahlich J: Hospitalization          costs and length of stay of Japanese children with respiratory syncytial virus: A          structural equation modeling approach. Medicine (Baltimore) 2018; 97: e11491.          PMID:30024527 https:\/\/doi.org\/10.1097\/MD.0000000000011491","DOI":"10.1097\/MD.0000000000011491"},{"key":"3","unstructured":"3. Hutton DW: Economic analysis of nirsevimab in          pediatric populations; ACIP General Meeting, February 23, 2023.          https:\/\/www.cdc.gov\/acip\/downloads\/slides-2023-02-22-24\/RSV-Pediatric-02-Hutton-508.pdf."},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Hammitt LL, Dagan R, Yuan Y, Baca Cots M, Bosheva          M, Madhi SA, Muller WJ, Zar HJ, Brooks D, Grenham A, W\u00e4hlby Hamr\u00e9n U, Mankad VS, Ren P,          Takas T, Abram ME, Leach A, Griffin MP, Villafana T, MELODY Study Group: Nirsevimab for          prevention of RSV in healthy late-preterm and term infants. N Engl J Med 2022; 386:          837\u2013846. PMID:35235726 https:\/\/doi.org\/10.1056\/NEJMoa2110275","DOI":"10.1056\/NEJMoa2110275"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Zar HJ, Sim\u00f5es EA, Madhi SA, Ramilo O, Senders          SD, Shepard JS, Laoprasopwattana K, Piedrahita J, Novoa JM, Vargas SL, Dionne M, Jackowska          T, Liu E, Ishihara Y, Ikeda K, Zhang Y, Railkar RA, Lutkiewicz J, Vora KA, Zang X, Maas          BM, Lee AW, Guerra A, Sinha A, CLEVER (MK-1654-004) Study Group: Clesrovimab for          prevention of RSV disease in healthy infants. N Engl J Med 2025; 393: 1292\u20131303.          PMID:40961446 https:\/\/doi.org\/10.1056\/NEJMoa2502984","DOI":"10.1056\/NEJMoa2502984"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Gebretekle GB, Yeung MW, Ximenes R, Cernat A,          Simmons AE, Killikelly A, Siu W, Rafferty E, Brousseau N, Tunis M, Tuite AR:          Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory          syncytial virus disease in Canadian infants. Vaccine 2024; 42: 126164. PMID:39079810          https:\/\/doi.org\/10.1016\/j.vaccine.2024.126164","DOI":"10.1016\/j.vaccine.2024.126164"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Kieffer A, Beuvelet M, Moncayo G, Chetty M,          Sardesai A, Musci R, Hudson R: Disease burden associated with all infants in their first          RSV season in the UK: A static model of universal immunization with nirsevimab against          RSV-related outcomes. Infect Dis Ther 2024; 13: 2135\u20132153. PMID:39235703          https:\/\/doi.org\/10.1007\/s40121-024-01037-7","DOI":"10.1007\/s40121-024-01037-7"}],"container-title":["The Keio Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/75\/3\/75_2025-0020-LE\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:19:49Z","timestamp":1790396389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/75\/3\/75_2025-0020-LE\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2302\/kjm.2025-0020-le","relation":{},"ISSN":["0022-9717","1880-1293"],"issn-type":[{"value":"0022-9717","type":"print"},{"value":"1880-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2025-0020-LE"}}